Value-based pricing Archives -

Pharmaceutical companies have said they will try to carve months off the time between approval and launch for

Drugmakers pledge shorter launch times for drugs in EU

https://pharmaphorum.com/news/drugmakers-pledge-shorter-launch-times-for-drugs-in-eu/

Novo Nordisk has said that the introduction of value-based procurement (VBP) for insulin products by the Chinese government

China’s insulin plans will hit 2022 revenues, says Novo Nordisk

https://pharmaphorum.com/news/chinas-insulin-plans-will-hit-2022-revenues-says-novo-nordisk/

The method used by the US Institute for Clinical and Economic Review (ICER) to gauge whether drugs are

ICER methods could be illegal in US, claims US think tank

https://pharmaphorum.com/news/icer-methods-could-be-illegal-in-us-claims-us-think-tank/

With the US joining other countries around the world in demanding definitions and measurements of the value of

Demonstrating value – the future for market access

https://pharmaphorum.com/views-and-analysis/demonstrating-value-future-market-access/

The age of digital and wearables is upon us – but how can we realise its full potential?

Realising the true potential of health wearables

https://pharmaphorum.com/views-and-analysis/realising-true-potential-health-wearables/

Value-based pricing